The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the safety of testosterone. The study involved roughly 800 older men with low testosterone and symptoms related to this illness, like http://tinyurl.com/hvm4td7 physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.
The recent contradictory findings on testosterone treatment prompted Patel and his team to conduct a substantial systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the USA suffer from low testosterone, which happens when the body does not make enough hormones as a result of a problem with the testicles or pituitary gland. This describes clear aging, somebody's sudden weight gain and decline of energy.
No clear lower limit of testosterone was confirmed; yet 15 ng per dL (0.5 nmol per L) generally is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all scenarios and absent or markedly decreased climaxes. Due to studies similar to this, supplemented with anecdotal evidence, many girls have been started on testosterone therapy. Most women can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well being are common criticisms of postmenopausal women.